Literature DB >> 15955054

The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology.

Roberto Maggio1, Francesca Novi, Marco Scarselli, Giovanni U Corsini.   

Abstract

Although highly controversial just a few years ago, the idea that G-protein-coupled receptors (GPCRs) may undergo homo-oligomerization or hetero-oligomerization has recently gained considerable attention. The recognition that GPCRs may exhibit either dimeric or oligomeric structures is based on a number of different biochemical and biophysical approaches. Although much effort has been spent to demonstrate the mechanism(s) by which GPCRs interact with each other, the physiological relevance of this phenomenon remains elusive. An additional source of uncertainty stems from the realization that homo-oligomerization and hetero-oligomerization of GPCRs may affect receptor binding and activity in different ways, depending on the type of interacting receptors. In this brief review, the functional and pharmacological effects of the hetero-oligomerization of GPCR on binding and cell signaling are critically analyzed.

Mesh:

Substances:

Year:  2005        PMID: 15955054     DOI: 10.1111/j.1742-4658.2005.04729.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  22 in total

1.  Increased abundance of opioid receptor heteromers after chronic morphine administration.

Authors:  Achla Gupta; Jan Mulder; Ivone Gomes; Raphael Rozenfeld; Ittai Bushlin; Edmund Ong; Maribel Lim; Emeline Maillet; Mats Junek; Catherine M Cahill; Tibor Harkany; Lakshmi A Devi
Journal:  Sci Signal       Date:  2010-07-20       Impact factor: 8.192

Review 2.  Membrane protein prediction methods.

Authors:  Marco Punta; Lucy R Forrest; Henry Bigelow; Andrew Kernytsky; Jinfeng Liu; Burkhard Rost
Journal:  Methods       Date:  2007-04       Impact factor: 3.608

Review 3.  A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization.

Authors:  G Milligan
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

4.  Computational study of the heterodimerization between mu and delta receptors.

Authors:  Xin Liu; Ming Kai; Lian Jin; Rui Wang
Journal:  J Comput Aided Mol Des       Date:  2009-02-13       Impact factor: 3.686

5.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

6.  Secretin receptor oligomers form intracellularly during maturation through receptor core domains.

Authors:  Cayle S Lisenbee; Laurence J Miller
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

7.  Visualization of G protein-coupled receptor (GPCR) interactions in living cells using bimolecular fluorescence complementation (BiFC).

Authors:  Pierre-Alexandre Vidi; Julie A Przybyla; Cheng-Deng Hu; Val J Watts
Journal:  Curr Protoc Neurosci       Date:  2010-04

8.  Specific oligomerization of the 5-HT1A receptor in the plasma membrane.

Authors:  Andrew Woehler; Jakub Wlodarczyk; Evgeni G Ponimaskin
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

9.  Pharmacological endothelin receptor interaction does not occur in veins from ET(B) receptor deficient rats.

Authors:  Keshari Thakali; James J Galligan; Gregory D Fink; Cheryl E Gariepy; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2008-04-03       Impact factor: 5.773

10.  Transmembrane domain IV of the Gallus gallus VT2 vasotocin receptor is essential for forming a heterodimer with the corticotrophin releasing hormone receptor.

Authors:  Marina V Mikhailova; Jonathan Blansett; Sandie Jacobi; Philip R Mayeux; Lawrence E Cornett
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.